CEG vs PFE: Which Is the Better Buy?
Side-by-side comparison of Constellation Energy Corporation and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-22.
Constellation Energy Corporation · Utilities
$262.11
-4.2% upside to fair value
Med Conviction
Grade C
High Quality
VS
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+12.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CEG |
PFE |
| Current Price |
$262.11 |
$27.64 |
| Fair Value Estimate |
$250.98 |
$30.94 |
| Upside to Fair Value |
-4.2%
|
+12.0%
|
| Market Cap |
$94.1B |
$157.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
13.9x
|
17.4x
|
| Price / Sales |
3.0x
|
2.5x
|
| Price / FCF |
300.3x
|
14.3x
|
| Revenue Growth YoY |
+23.0%
|
+2.6%
|
| Gross Margin |
94.9%
|
71.3%
|
| Operating Margin |
14.7%
|
25.1%
|
| Return on Equity |
14.7%
|
4.9%
|
| Dividend Yield |
0.64% |
6.22% |
| FCF Yield |
0.33%
|
6.97%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Constellation Energy is the largest U.S. producer of carbon-free electricity, operating roughly 32,400 megawatts of nuclear, gas, wind, solar, and hydro generation across the Mid-Atlantic, Midwest, New York, ERCOT, and other power markets, with a 94.9% TTM gross margin that reflects the low marginal cost of nuclear fuel and the scarcity value of firm clean power. The business quality is genuinely…
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Accumulation Zones
| Metric |
CEG |
PFE |
| Zone Low |
$188.23 |
$23.21 |
| Zone High |
$213.33 |
$26.30 |
| In Buy Zone? |
No
|
No
|